HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria.

Abstract
In Nigeria chloroquine remains the drug of choice for the treatment of falciparum malaria since chloroquine resistance is not yet a problem. Nevertheless, in view of the rapid spread of multi-resistant Plasmodium falciparum in Africa, it is desirable to test alternative drugs for efficacy and safety. To this end we undertook a comparative controlled trial of the new triple combination, mefloquine-sulphadoxine-pyrimethamine (MSP, Fansimef, Hoffman-La Roche, Switzerland) with chloroquine in a group of Nigerian children with symptomatic falciparum malaria. Our results showed that Fansimef was a rapidly acting blood schizontocide against the Nigerian strain of P. falciparum, and was well tolerated. In particular, sinus bradycardia, which was frequently observed with Fansimef in the trials conducted in Zambia, was not seen in any of the Nigerian patients.
AuthorsA Fadeke Aderounmu, L A Salako, A J Laoye, J Modupe Makinde, R Aina Adio
JournalAfrican journal of medicine and medical sciences (Afr J Med Med Sci) Vol. 17 Issue 4 Pg. 195-200 (Dec 1988) ISSN: 0309-3913 [Print] Nigeria
PMID2854365 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antimalarials
  • Drug Combinations
  • Quinolines
  • Sulfanilamides
  • mefloquine-sulfadoxine-pyrimethamine
  • Sulfadoxine
  • Chloroquine
  • Mefloquine
  • Pyrimethamine
Topics
  • Animals
  • Antimalarials (therapeutic use)
  • Child
  • Chloroquine (therapeutic use)
  • Clinical Trials as Topic
  • Drug Administration Schedule
  • Drug Combinations (therapeutic use)
  • Drug Resistance
  • Female
  • Humans
  • Malaria (drug therapy)
  • Male
  • Mefloquine (analogs & derivatives)
  • Nigeria
  • Plasmodium falciparum (drug effects, isolation & purification)
  • Pyrimethamine (therapeutic use)
  • Quinolines (therapeutic use)
  • Random Allocation
  • Sulfadoxine (therapeutic use)
  • Sulfanilamides (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: